Azitra (AZTR) has had the highest return this decade by a US stock in the Biotechnology Industry, returning 5,578.6%.

ASSET	DECADE	% RETURN
Azitra (AZTR)	2020s	5,578.57%
Indivior PLC Ordinary Shares (INDV)	2020s	1,949.65%
Summit Therapeutics (SMMT)	2020s	1,366.56%
Capricor Therapeutics (CAPR)	2020s	902.31%
Celldex Therapeutics (CLDX)	2020s	773.66%
NewAmsterdam Pharma Company NV Warrant (NAMSW)	2020s	698%
Protagonist Therapeutics (PTGX)	2020s	527.5%
Catalyst Pharmaceuticals (CPRX)	2020s	517.11%
ADMA Biologics (ADMA)	2020s	441.09%
Belite Bio Inc ADR (BLTE)	2020s	365.84%
Natera (NTRA)	2020s	354.19%
Chimerix (CMRX)	2020s	316.59%
Nuvalent (NUVL)	2020s	305.97%
MoonLake Immunotherapeutics (MLTX)	2020s	287.99%
argenx NV ADR (ARGX)	2020s	283.51%
Cytokinetics (CYTK)	2020s	279.98%
TG Therapeutics (TGTX)	2020s	272.01%
Anavex Life Sciences (AVXL)	2020s	258.17%
Madrigal Pharmaceuticals (MDGL)	2020s	256.6%
MannKind (MNKD)	2020s	256.39%
Halozyme Therapeutics (HALO)	2020s	239.26%
Arcellx (ACLX)	2020s	235.32%
Biohaven Pharmaceutical (BHVN)	2020s	230.67%
United Therapeutics (UTHR)	2020s	229.8%
Merus (MRUS)	2020s	209.01%